PHOX2B levels, together with CRMP1, DBH, DDC, GAP43, ISL1 and TH, belong to the gene expression signature used to predict the NB outcome [220], whereby high levels of PHOX2B correlate with worse prognosis [221]. This evidence concerns the gene PHOX2B and neuroblastoma.